KRMD

KORU Medical Systems Inc. Common Stock (DE) (KRMD)

Stock · NASDAQ · Health Care

$3.01as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 6, 2026

No recent news for KRMD. No new developments reported for KRMD in the past week.

Price chart

Open in TradingView

Active signals

Revenue-Price Divergence (6M)54.4%200 SMA Touch0.0%
Resistance level
$3.93
Industry
Medical/Dental Instruments

KRMD Signal Track Record

How signals performed across all stocks →

What KRMD's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike51-1.3%45%
Bollinger Band Breakout24-3.0%38%
Bollinger Band Breakdown14-5.4%29%
200-Day Moving Average TouchActive now11-8.0%36%
Any 20-session window (baseline)0.0%49%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About KRMD

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary i…

Sector
Health Care
Industry
Medical/Dental Instruments
Employees
73

Fundamentals

1-day range
$2.97$3.14
Market cap
$163.52M
P/E (trailing)
—
P/E (forward)
86.57
EPS (trailing)
$-0.04
Dividend yield
—
Beta
0.52
Avg. volume
246.2K
52-week range
$2.86$6.61
Next earnings: November 11, 2026 · EPS estimate $-0.02After Closeconfirmed

How KORU Medical Systems Inc. Common Stock (DE) Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$41.13MSG&A$23.38M (57%)Cost of Revenue$15.52M (38%)R&D$4.39M (11%)Tax$21.9K (0%)KRMD

Source: 10-K filed Mar 12, 2026 · via SEC EDGAR / Finnhub

Gross Profit$25.60M(62%)
Operating Income-$2.97M(-7%)

Forecasts

4 analyst ratings

Buy 80%
Hold 20%
Sell 0%
1-year price forecast
High
$8
+165.8%
Median
$6
+99.3%
Low
$5
+66.1%

KORU Medical Systems Inc. Common Stock (DE) Competitors

Chosen by industry and closest market cap.

  • KRMD
    KORU Medical Systems Inc. Common Stock (DE)
    $3
    ▼ 0.99%
    Market cap $163.52MP/E —
    $2.86$6.61
  • CVRX
    CVRx Inc. Common Stock
    $1.3
    ▼ 6.47%
    Market cap $157.62MP/E —
    $1.28$11.3
  • STIM
    Neuronetics Inc. Common Stock
    $1.88
    ▼ 3.33%
    Market cap $156.57MP/E —
    $0.8$3.44
  • APYX
    Apyx Medical Corporation Common Stock
    $2.55
    ▼ 0.39%
    Market cap $174.35MP/E —
    $2.32$5.08
  • RCEL
    Avita Medical Inc. Common Stock
    $13.04
    ▼ 2.76%
    Market cap $146.19MP/E —
    $3.22$13.73
  • LUCD
    Lucid Diagnostics Inc. Common Stock
    $0.478
    ▼ 8.08%
    Market cap $193.54MP/E —
    $0.5$1.63
  • MBOT
    Microbot Medical Inc. Common Stock
    $0.95
    ▲ 0.00%
    Market cap $120.90MP/E —
    $0.99$3.04

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
725.3K
Disposed
25.5K

Institutional Ownership

March 31, 2026

Total shares held
20.24M
Total value held
$87.16M
Institutional holders
87
Top holders this quarter
  • Unknown3.77M
  • Unknown3.51M
  • Unknown2.37M
  • Unknown1.69M
  • Unknown1.05M
  • Unknown811.2K
  • Unknown760.5K
  • Unknown703.1K
  • Unknown649.2K
  • Unknown642.9K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.